Louise Ainley

5PUBLICATIONS
8CO-AUTHORS
Innate immunityPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 30, 2026
Immune clues to infection risk in myeloma.

|Nov 23, 2021
Applying current smouldering myeloma risk models to a UK single-centre cohort and clinical features at progression.

Louise Ainley, Marquita Camilleri, Selina J Chavda

|Oct 11, 2021
Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV-19 COVID-19 vaccine after first and second doses in patients with plasma cell disorders: influence of host and disease factors.

Wei Yee Chan, Lara Howells, William Wilson

|Jul 29, 2021
Development of antibody response to SARS-CoV-2 following asymptomatic infection in patients with plasma cell disorders on immunomodulatory therapy.

Wei Yee Chan, Emilie Sanchez, Selina J Chavda

|Nov 25, 2020
DT-PACE/ESHAP chemotherapy regimens as salvage therapy for multiple myeloma prior to autologous stem cell transplantation.

Louise Ainley, Selina J Chavda, Nicholas Counsell

Pageof 1

Frequent Collaborators

5 joint publications

Kwee Yong

4 joint publications

Selina J Chavda

2 joint publications

Wei Yee Chan

2 joint publications

Catherine S Y Lecat